Medpace Holdings, Inc. (MEDP) vs Oracle Corporation (ORCL)
A side-by-side comparison of Medpace Holdings, Inc. and Oracle Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: MEDP is classified in Healthcare; ORCL is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
MEDP
Medpace Holdings, Inc.
$570.97HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
ORCL
Oracle Corporation
$119.99TechnologyDelayed quote: Jul 28, 2026, 3:59 PM EDT
Total return — MEDP vs ORCL
growth of $100 · dividends reinvested · last 10yMEDP +2020.8%ORCL +238.7%MEDP compounded faster
Log scale — wide-divergence pair
MEDP ORCL
MEDP vs ORCL: by the numbers
- •ORCL is the larger company ($345.63B vs $15.94B market cap).
- •ORCL trades at the lower trailing earnings multiple (20.57 vs 34.53 P/E), one valuation lens rather than an overall verdict.
- •ORCL converts more revenue to profit (25.37% vs 17.67% net margin).
- •MEDP grew revenue faster over the past five years (22.03% vs 10.72% CAGR).
- •ORCL pays a dividend (1.67% yield), while MEDP has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MEDP | ORCL |
|---|---|---|
| P/E ratio | 34.53 | 20.57 |
| Forward P/E | 33.60 | 16.01 |
| P/S ratio | 6.09 | 5.19 |
| P/B ratio | 39.07 | 8.22 |
| PEG ratio | 1.82 | 1.26 |
| EV / EBITDA | 27.73 | 16.52 |
| FCF yield | 4.51% | N/A |
Profitability
| Metric | MEDP | ORCL |
|---|---|---|
| Gross margin | 28.76% | 65.81% |
| Operating margin | 20.97% | 30.85% |
| Net margin | 17.67% | 25.37% |
| ROE | 113.29% | 40.20% |
| ROIC | 67.94% | 7.99% |
Dividends
| Metric | MEDP | ORCL |
|---|---|---|
| Dividend yield | N/A | 1.67% |
| Payout ratio | N/A | 33.67% |
Growth (annualized)
| Metric | MEDP | ORCL |
|---|---|---|
| Revenue CAGR (5Y) | 22.03% | 10.72% |
| EPS CAGR (5Y) | 30.90% | 4.93% |
| FCF CAGR (5Y) | 24.42% | -13.18% |
| Total return CAGR (5Y) | 28.06% | 7.88% |
Frequently asked
- Which has the lower trailing P/E, MEDP or ORCL?
- ORCL has the lower trailing P/E: MEDP trades at 34.53 and ORCL at 20.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, MEDP or ORCL?
- Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus ORCL at 10.72%.
- Does MEDP or ORCL pay a bigger dividend?
- ORCL pays a dividend (1.67% yield), while MEDP has no payments in the available dividend history.
- Is MEDP or ORCL more profitable?
- ORCL runs the higher net margin — MEDP at 17.67% versus ORCL at 25.37%.
- How have MEDP and ORCL total returns compared?
- Over the past 5 years, MEDP delivered 28.06% and ORCL delivered 13.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Medpace P/E ratioOracle P/E ratioMedpace dividend yieldOracle dividend yieldMedpace ROEOracle ROEMedpace operating marginOracle operating marginMedpace revenue growthOracle revenue growthMedpace free cash flowOracle free cash flow
Medpace & Oracle appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.